Cargando…
Sars-Cov-2 Vaccinations Do Not Lead to Progression of Monoclonal Gammopathy of Undetermined Significance: Results from the Population-Based Istopmm Screening Study
Autores principales: | Palmason, Robert, Eythorsson, Elias, Rögnvaldsson, Sæmundur, Thorsteinsdottir, Sigrun, Ekberg, Sara, Crowther, Michael, Reed, Elin Ruth, Oskarsson, Jon Þórir, Sigurdardottir, Gudrun Asta, Aspelund, Thor, Vidarsson, Brynjar, Onundarson, Pall Torfi, Agnarsson, Bjarni Agnar, Sigurdardottir, Margret, Thorsteinsdottir, Ingunn, Sveinsdottir, Signy Vala, Olafsson, Isleifur, Thordardottir, Asdis Rosa, Jonsson, Asbjorn, Indridason, Olafur Skuli, Gislason, Gauti, Olafsson, Andri, Sigurdsson, Jon Kristinn, Steingrimsdottir, Hlif, Einarsson Long, Thorir, Hultcrantz, Malin, Durie, Brian G.M., Harding, Stephen, Landgren, Ola, Palsson, Runolfur, Love, Thorvardur Jon, Kristinsson, Sigurdur Y |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The American Society of Hematology. Published by Elsevier Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9665214/ http://dx.doi.org/10.1182/blood-2022-157138 |
Ejemplares similares
-
Defining new reference intervals for serum free light chains in individuals with chronic kidney disease: Results of the iStopMM study
por: Long, Thorir Einarsson, et al.
Publicado: (2022) -
P900: INVOLVED/UNINVOLVED SERUM FREE LIGHT CHAIN RATIO IS A STRONGER PREDICTOR OF DIAGNOSTIC/RISK FACTORS IN LIGHT CHAIN COMPARED TO HEAVY CHAIN MONOCLONAL GAMMOPATHIES
por: Thorir Oskarsson, Jon, et al.
Publicado: (2023) -
Monoclonal Gammopathy of Undetermined Significance and COVID-19: Results from the Population-Based Iceland Screens Treats or Prevents Multiple Myeloma Study (iStopMM)
por: Rögnvaldsson, Sæmundur, et al.
Publicado: (2021) -
P894: INFECTION RISK BEFORE DIAGNOSIS OF MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE: RESULTS FROM THE SCREENED POPULATION-BASED ISTOPMM STUDY
por: Ros Levy, Marina, et al.
Publicado: (2023) -
Iceland screens, treats, or prevents multiple myeloma (iStopMM): a population-based screening study for monoclonal gammopathy of undetermined significance and randomized controlled trial of follow-up strategies
por: Rögnvaldsson, Sæmundur, et al.
Publicado: (2021)